These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 6368059)
1. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Homberg JC; Andre C; Abuaf N Clin Exp Immunol; 1984 Mar; 55(3):561-70. PubMed ID: 6368059 [TBL] [Abstract][Full Text] [Related]
2. [Hepatic lesions associated with antimicrosomal antibodies of the liver and kidney (type 2) and the taking of tienilic acid. A study of 37 cases]. Lafay JP; Poupon R; Legendre C; Homberg JC; Darnis F Gastroenterol Clin Biol; 1983 May; 7(5):523-8. PubMed ID: 6873565 [No Abstract] [Full Text] [Related]
4. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968 [TBL] [Abstract][Full Text] [Related]
5. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Homberg JC; Abuaf N; Helmy-Khalil S; Biour M; Poupon R; Islam S; Darnis F; Levy VG; Opolon P; Beaugrand M Hepatology; 1985; 5(5):722-7. PubMed ID: 4029887 [TBL] [Abstract][Full Text] [Related]
6. Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450 IIC11. Pons C; Dansette PM; Amar C; Jaouen M; Wolf CR; Gregeois J; Homberg JC; Mansuy D J Pharmacol Exp Ther; 1991 Dec; 259(3):1328-34. PubMed ID: 1762080 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders. Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868 [TBL] [Abstract][Full Text] [Related]
8. Immune mechanisms in tienilic acid associated hepatotoxicity. Neuberger J; Williams R Gut; 1989 Apr; 30(4):515-9. PubMed ID: 2714684 [TBL] [Abstract][Full Text] [Related]
9. [Chronic hepatitis with elevated level of endoplasmic anti-reticulum antibodies: alpha-methyldopa or tienilic acid?]. Beaugrand M; Gavillon C; Ferrier JP Gastroenterol Clin Biol; 1981; 5(8-9):819-20. PubMed ID: 7297821 [No Abstract] [Full Text] [Related]
10. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera. Robin MA; Maratrat M; Le Roy M; Le Breton FP; Bonierbale E; Dansette P; Ballet F; Mansuy D; Pessayre D J Clin Invest; 1996 Sep; 98(6):1471-80. PubMed ID: 8823314 [TBL] [Abstract][Full Text] [Related]
11. Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases. Manns M; Meyer zum Büschenfelde KH; Slusarczyk J; Dienes HP Clin Exp Immunol; 1984 Sep; 57(3):600-8. PubMed ID: 6467682 [TBL] [Abstract][Full Text] [Related]
12. Counterimmunoelectrophoresis (CIE) for the detection of anti-liver-kidney microsome (LKM) antibodies in the sera of patients with chronic liver disease. Lenzi M; Fusconi M; Selleri L; Caselli A; Cassani F; Bianchi FB; Pisi E J Immunol Methods; 1988 Jul; 111(2):253-9. PubMed ID: 3397549 [TBL] [Abstract][Full Text] [Related]
13. [Tienilic acid as a likely cause of "auto immune" active hepatitis (author's transl)]. Eugène C; Patriarche C; Bergue A; Quevauvilliers J Nouv Presse Med; 1980 Jun; 9(27):1885-7. PubMed ID: 6157146 [TBL] [Abstract][Full Text] [Related]
14. [Tienilic acid can induce acute hepatitis, chronic hepatitis and cirrhosis. A report of three cases (author's transl)]. Pariente EA; André C; Zafrani ES; Métreau JM; Dhumeaux D; Berthelot P Gastroenterol Clin Biol; 1981 May; 5(5):567-71. PubMed ID: 7250606 [No Abstract] [Full Text] [Related]
15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
16. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis]. Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466 [TBL] [Abstract][Full Text] [Related]
17. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049 [TBL] [Abstract][Full Text] [Related]